+104.6%
GSK vs XLRE
+106.6%
-2.0%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | XLRE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | -1.0% | +0.9% | +0.3% |
| 7D | -5.3% | -4.3% | -1.0% | -3.5% |
| 30D | -3.7% | +1.0% | -4.6% | -4.0% |
| 3M | -7.3% | -5.0% | -2.2% | -5.1% |
| 6M | -4.2% | -2.8% | -1.5% | -3.0% |
| YTD | +0.9% | +7.8% | -6.9% | -2.2% |
| 1Y | +7.3% | +8.9% | -1.6% | +3.5% |
| 3Y | +52.7% | +29.8% | +22.9% | +36.2% |
| 5Y | +40.1% | +4.4% | +35.7% | +35.2% |
| 10Y | +98.7% | +101.7% | -3.0% | +41.1% |
| All | +104.6% | +106.6% | -2.0% | +45.9% |
Cumulative growth
Daily Returns
Daily percentage return beside XLRE.
Daily Out/Under-Performance
Portfolio return minus XLRE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × XLRE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded XLRE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling